Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.5 has been applied, replacing the previous Revision: v3.5.4. This represents a minor software update to the interface and does not modify any study data or displayed content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 in the Study Documents, indicating a new version of documents is available. This reflects updated Protocol and Statistical Analysis Plan materials associated with the AbbVie study.SummaryDifference0.0%

- Check46 days agoChange DetectedThe website’s ClinicalTrials.gov footer was updated from revision v3.5.2 to v3.5.3, indicating a platform release/version update.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded 'State of Vienna' as the location designation and updated Vienna addresses to 'Vienna, State of Vienna, Austria, 1030' and '1090', replacing the previous 'Vienna' entries. Also updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. The study details and page layout appear unchanged.SummaryDifference0.0%

- Check96 days agoChange Detected- Revision metadata updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.